Fatéméh Dubois

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.3kcitations127works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hippo pathway signaling and YAP/TAZ(44), Ubiquitin and proteasome pathways(15), Cancer-related gene regulation(14), Cancer, Hypoxia, and Metabolism(12), PI3K/AKT/mTOR signaling in cancer(9)

Publications127 total

NDRG1 as a sensor and mediator of endothelial stress: from homeostasis to inflammation and cardiovascular disease
Cellular and Molecular Life Sciences·2025· 2 citedOpen Access
Apolipoproteins in circulation: At the interface of thrombosis and stroke initiation
Progress in Lipid Research·2025· 1 citedOpen Access
Apolipoproteins in ischemic stroke progression and recovery: Key molecular mechanisms and therapeutic potential
Neurobiology of Disease·2025· 3 citedOpen Access
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
International Journal of Oncology·2024· 3 citedOpen Access
Combining sophisticated fast FLIM, confocal microscopy, and STED nanoscopy for live-cell imaging of tunneling nanotubes
Life Science Alliance·2024· 14 citedOpen Access
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Cell Death and Disease·2023· 11 citedOpen Access
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial
Lung Cancer·2023· 2 citedOpen Access
Paxillin regulates Rab5-mediated vesicle motility through modulating microtubule acetylation
Molecular Biology of the Cell·2023· 4 citedOpen Access
Supplementary Figure Legends 1-5 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 3 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 2 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Table 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 4 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Table 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 3 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Data from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Data from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 2 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Guénaëlle Levallet(27), Emmanuel Bergot(20), Gérard Zalcman(17), Jérôme Levallet(11), H. Bricard(9), D. Laroche(8), Christian Créveuil(8), Franck Morin(8), Martine Antoine(7), Céline Bazille(7), Elodie Maille(7), M Vergnaud(6), Jacques Camonis(6), Denis Moro‐Sibilot(6), Nicolas Elie(6), Maureen Keller(5), Julien Mazières(5), C Lefrançois(5), Virginie Westeel(5), Élisabeth Quoix(5)